Genes and Development Ph.D. Program
Basic Science on Cancer and Disease
The Genes and Development Ph.D. Program (G&D) is for students seeking advanced training in biomedical research on the fundamental molecular mechanisms that control growth and cell differentiation, and that cause cancer and other human diseases.
Research in our program labs covers a broad spectrum of modern biomedical interests including Genetics, Genomics and Epigenetics; Cancer Biology; Stem Cells and Development; and Biochemistry and Biomolecular Structure. Diverse experimental systems, including mice, frogs, worms, fruit flies, sea urchins, yeast and human cells, are used by G&D faculty and graduate students to conduct their research.
Located in Houston, Texas, in the heart of the world’s largest medical center, the G&D Program provides an exceptional setting for biomedical research and graduate education. Browse through our pages and you’ll discover an outstanding program that prepares students for successful biomedical research careers in academia, industry and government and other biomedical-related professions.
For more information, please read this message from our program director.
G&D Student Wins McGovern Award for Presentation Skills
Congratulations to Lindsey Minter (Barton Lab) for her first place finish in the 2013 John P. McGovern Award for Presentation Skills! Read more about her impressive achievement here.
G&D Faculty Member Appointed Graduate School Dean
Dr. Michelle Barton was appointed Dean of the UT Graduate School of Biomedical Sciences effective July 2, 2012. She and the other new Dean, Dr. Michael Blackburn of UT Health, replace Dr. George Stancel who served as Dean of the Graduate School for 13 years. Dr. Barton will continue running her laboratory research program while serving as Dean.
Ladbury Lab: Nature Structural and Molecular Biology, Apr 14, 2013. Suen KM, et al. Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli. PMID: 23584453
Flores Lab: Cell Metabolism, October 3, 2012. Su, X et al. TAp63 Is a Master Transcriptional Regulator of Lipid and Glucose Metabolism. PMID: 23040072
Ladbury Lab: Cell, June 22, 2012. Lin CC, et al. Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2. PMID: 22726438
Lozano Lab: Cancer Cell, June 12, 2012. Jackson JG, et al. p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer. PMID: 22698404
Dent Lab: Cell, September 2, 2011. Latham JA, et al. Chromatin signaling of kinetochores: trans-regulation of Dam1 methylation by histone H2B ubiquitination. PMID: 21884933
Barton Lab: Nature, December 16, 2010. Tsai W-W, et al. TRIM24 links a non-canonical histone signature to breast cancer. PMID: 21164480
Flores Lab: Nature, October 21, 2010. Su X, et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs. PMID: 20962848